Research Presented at AUA 2024 Indicates the Cost of Prescription Drugs Is A Significant Barrier To Care
Researchers will present their study findings covering important updates on the cost of care in San Antonio, Texas, from May 3 to 6.
SAN ANTONIO, May 05, 2024 (GLOBE NEWSWIRE) -- Abstracts being presented at the American Urological Association's Annual Meeting discuss the Mark Cuban Cost Plus Drug Company and treatment of urogynecologic conditions as well as the cost barriers to peri- and post-menopausal women using vaginal estrogen therapy.
Researchers will present their study findings covering important updates on the cost of care in San Antonio, Texas, from May 3 to 6. Ruchika Talwar, MD, urologist and clinical instructor in the Vanderbilt University School of Medicine’s Department of Urology, moderated a virtual press session with the abstract authors, providing key insights into their research.
“The more we highlight and disseminate these findings, the more we can make both urologists and patients aware of the resources that exist to help mitigate the financial burden of prescription drugs,” said Dr. Talwar. “It’s important to note that it can often be cheaper for a patient to go outside of their insurance and use a company like the Mark Cuban Cost Plus Drug Company, especially for vaginal estrogen therapy.”
The following abstracts are covered in the moderated panel:
- The Mark Cuban Cost Plus Drug Company Effect On Urogynecologic Drugs
- Barriers to Peri- and Post- Menopausal Women using Vaginal Estrogen Therapy include Cost and Fear of Side Effects
A recording of the panel discussion is available to all press registrants. Fill out the registration form on the website to be added to the virtual programming: https://www.auanet.org/AUA2024/register/press-registration
NOTE TO REPORTERS: Presenting authors and moderators are available to discuss their findings. To arrange an interview with an expert, please contact the AUA Communications Team at [email protected].
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 25,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
Corey Del Bianco American Urological Association 410-689-4033 [email protected]